VBI Vaccines Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer
July 25, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - July 25, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is pleased to announce the appointment of Dr. Francisco Diaz-Mitoma, M.D.,...
VBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus
July 19, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - July 19, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") today announced that it has applied its clinical-stage eVLP Platform to the...
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
June 23, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - June 23, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") has received a No Objection Letter from Health Canada, providing clearance to...
VBI Vaccines Announces Closing of $13.6 Million Private Placement
June 21, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - June 21, 2016) - VBI Vaccines (NASDAQ:VBIV)(TSX:VBV) ("VBI"), today announced the closing of an equity private placement financing led by OPKO...
VBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference
June 17, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - June 17, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the Virus-Like Particle and Nano-Particle Vaccines...
VBI Vaccines Announces Medulloblastoma Immunotherapy Program
June 16, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - June 16, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") today announced that it is developing a novel therapeutic vaccine candidate for...
VBI Vaccines to Host Hepatitis B Key Opinion Leader Meeting
June 10, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - June 10, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") will host a hepatitis B ("HBV") Key Opinion Leader meeting on Monday, June 13 at...
VBI Vaccines to Present at the BIO International Convention
June 03, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - June 3, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the 2016 BIO International Convention on Monday, June...
VBI Vaccines to Present at the Jefferies Healthcare Conference
May 27, 2016 08:30 ET
|
VBI Vaccines Inc.
CAMBRIDGE, MASSACHUSETTS--(Marketwired - May 27, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the Jefferies 2016 Healthcare Conference on Friday,...
SciVac Therapeutics Inc.: News Release
May 02, 2016 17:30 ET
|
SciVac Therapeutics Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 2, 2016) - SciVac Therapeutics Inc. ("SciVac" or the "Company") (TSX:VAC)(OTCQX:SVACD) today announced, in connection with the previously...